Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | OT-A201 |
Synonyms | |
Therapy Description |
Limited information is currently available on OT-A201 (Jul 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
OT-A201 | OT A201|OTA201 | Limited information is currently available on OT-A201 (Jul 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05828459 | Phase I | Lenalidomide + OT-A201 OT-A201 OT-A201 + Paclitaxel Bevacizumab + OT-A201 OT-A201 + Pomalidomide | First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors | Recruiting | FRA | 0 |